| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
China Biopharma Strikes Deal For Antiviral
Posted on 06/22/2007 08:22:24 | Link | Post Comment
by Richard Daverman, PhD
ChinaBio Today
HPV Herbal Drug Will Seek OTC Approval in US, Europe
China Biopharma (Bulletin Board: CBPC) signed a deal with Soonfast Pharmaceutical Service & Technology Co., Ltd., allowing China Biopharma to introduce an antiviral medicine for human papillomavirus (HPV) and herpes simplex virus (HSV) in the US and Europe.
The medication is a natural, topical drug that has been shown in tests to inhibit the growth of HPV and HSV. In two to three days, it has reduced the infection from the virus by 90%. In experiments, the herbal drug has killed all of the HPV types 6/11/16/18 and 33.
HPVs are the most common sexually transmitted viral agents in the US. They have infected up to 20% of the people aged 15 to 49. No currently available drug completely eliminates the infection.
China Biopharma and Soonfast will join in conducting tests in China and the US to obtain regulatory permission to market the herbal drug as an OTC medication.
Terms of the agreement were not disclosed.
At present, China Biopharma makes and distributes vaccines in China (see story). Its products target influenza, hemorrhagic fever, and Japanese Encephalitis.
RELATED READING:
- China Meditech Pays $3.3 Million for R&D Facility
- Chi-Med Rumoured Close to Signing Major Deal
- Shijiazhuang Pharma Bought by Legend, Goldman Sachs
ChinaBio Today is a regular contributor to BioHealth Investor
_______________
ChinaBio Today
HPV Herbal Drug Will Seek OTC Approval in US, Europe
China Biopharma (Bulletin Board: CBPC) signed a deal with Soonfast Pharmaceutical Service & Technology Co., Ltd., allowing China Biopharma to introduce an antiviral medicine for human papillomavirus (HPV) and herpes simplex virus (HSV) in the US and Europe.
The medication is a natural, topical drug that has been shown in tests to inhibit the growth of HPV and HSV. In two to three days, it has reduced the infection from the virus by 90%. In experiments, the herbal drug has killed all of the HPV types 6/11/16/18 and 33.
HPVs are the most common sexually transmitted viral agents in the US. They have infected up to 20% of the people aged 15 to 49. No currently available drug completely eliminates the infection.
China Biopharma and Soonfast will join in conducting tests in China and the US to obtain regulatory permission to market the herbal drug as an OTC medication.
Terms of the agreement were not disclosed.
At present, China Biopharma makes and distributes vaccines in China (see story). Its products target influenza, hemorrhagic fever, and Japanese Encephalitis.
RELATED READING:
- China Meditech Pays $3.3 Million for R&D Facility
- Chi-Med Rumoured Close to Signing Major Deal
- Shijiazhuang Pharma Bought by Legend, Goldman Sachs
ChinaBio Today is a regular contributor to BioHealth Investor
_______________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Credit Bloggers
- The Average Joe Investor
- Wishing Wealth
- Financial Skeptic
- Edmonton Real Estate
- Don't Mess With Taxes
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Tue Jul 22, 2008 09:23AM
Hedge funds have made billions this year shorting the banks, [read more]
Hedge funds have made billions this year shorting the banks, [read more]
<< My Home | TheMoneyBlogs Home